Rona Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 10

Rona Therapeutics General Information

Description

Developer of an RNA therapeutics platform designed for RNA medicine discovery. The company aims to establish innovative and disruptive RNA medicines with a proprietary platform to enable therapeutics with more specific, stable and prolonged effects. The company is building state-of-the-art facilities to expand nucleic acid synthesis, delivery platform, oligonucleotide chemical modification, RNA biology and manufacturing capability to realize the potential of powerful RNA therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 3, Lane 795, Kangwei Road
  • Pudong New Area
  • Shanghai, 201315
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Corporate Office
  • Building 3, Lane 795, Kangwei Road
  • Pudong New Area
  • Shanghai, 201315
  • China
+86 021

Rona Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rona Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 09-Oct-2025 Completed Clinical Trials - General
3. Early Stage VC 14-Mar-2025 Completed Clinical Trials - General
2. Early Stage VC (Series A1) 04-Apr-2024 $35M $68M Completed Clinical Trials - General
1. Early Stage VC (Series A) 07-Apr-2022 $33M $33M Completed Clinical Trials - General
To view Rona Therapeutics’s complete valuation and funding history, request access »

Rona Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
B Capital China Venture Capital Minority
Guanghua Kaiyuan Capital Asset Manager Minority
BioTrack Capital Venture Capital Minority
LongRiver Investments Venture Capital Minority
Zhongqi Capital Growth/Expansion Minority
You’re viewing 5 of 10 investors. Get the full list »

Rona Therapeutics FAQs

  • When was Rona Therapeutics founded?

    Rona Therapeutics was founded in 2021.

  • Where is Rona Therapeutics headquartered?

    Rona Therapeutics is headquartered in Shanghai, China.

  • What industry is Rona Therapeutics in?

    Rona Therapeutics’s primary industry is Drug Discovery.

  • Is Rona Therapeutics a private or public company?

    Rona Therapeutics is a Private company.

  • What is Rona Therapeutics’s current revenue?

    The current revenue for Rona Therapeutics is .

  • How much funding has Rona Therapeutics raised over time?

    Rona Therapeutics has raised $93M.

  • Who are Rona Therapeutics’s investors?

    B Capital China, Guanghua Kaiyuan Capital, BioTrack Capital, LongRiver Investments, and Zhongqi Capital are 5 of 10 investors who have invested in Rona Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process